A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Description

The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, standard of care therapy, etc.) while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness in these subjects. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.

Conditions

Choroidal Melanoma, Indeterminate Lesions of Eye

Study Overview

Study Details

Study overview

The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, standard of care therapy, etc.) while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness in these subjects. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Condition
Choroidal Melanoma
Intervention / Treatment

-

Contacts and Locations

Tucson

Retina Associates SW, P.C., Tucson, Arizona, United States, 85710

Los Angeles

UCLA Jules Stein Eye Institute, Los Angeles, California, United States, 90095

Palo Alto

Byers Eye Institute at Stanford University, Palo Alto, California, United States, 94303

Sacramento

Retina Consultants of Sacramento, Sacramento, California, United States, 95825

Boston

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States, 02114

Ann Arbor

W. K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, United States, 48105

Royal Oak

Associated Retinal Consultants, PC, Royal Oak, Michigan, United States, 48073

Minneapolis

Retina Center, Minneapolis, Minnesota, United States, 55404

New York

Columbia University Medical Center, New York, New York, United States, 10032

Portland

Oregon Health & Science University Casey Eye Institute, Portland, Oregon, United States, 97239

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Have been clinically diagnosed with primary IL or CM at the time of entry to a previous Aura Biosciences sponsored clinical trial.
  • * Have received AU-011 bel-sar or assigned to a different cohort or treatment arm (sham, SoC, etc.) an observation cohort in a previous Aura sponsored clinical trial.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Aura Biosciences,

Medical Monitor, STUDY_DIRECTOR, Aura Biosciences Inc.

Study Record Dates

2029-12